CNR1 and metabolic syndrome: Numerous studies demonstrated that CB1R blockade improves multiple parameters involved in metabolic syndrome and diabetes, such as waist circumference, glycemia, glycated hemoglobin, HDL and LDL cholesterol and triglycerides (13, 29, 30, 45).